Nanomedicine: Reshaping clinical practice

Journal of Internal Medicine

Volumn 267, Issue 1, 2010, Pages 2-8

  Fadeel, B ^a   Kasemo, B ^b   Malmsten, M ^c   Stromme M ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NANOFIBER; NANOMATERIAL;

CLINICAL PRACTICE; CLINICAL RESEARCH; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; NANOENGINEERING; NANOFABRICATION; NANOMEDICINE; NANOTECHNOLOGY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TISSUE REGENERATION;

CLINICAL MEDICINE; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 71949118148     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02186.x     Document Type: Conference Paper

References (18)

1. Elloumi-Hannachi I, Yamato M, Okano T. Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. J Intern Med 2010; 267: 54-70.
2. Jabbarzadeh E, Starnes T, Khan YM et al. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proc Natl Acad Sci USA 2008; 105: 11099-11104
3. Webber MJ, Stupp SI. Emerging peptide nanomedicine to regenerate tissues and organs. J Intern Med 2010; 267: 71-88.
4. Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG. Lipid-based nanotherapeutics for siRNA delivery. J Intern Med 2010; 267: 9-21.
5. Ozpolat B, Sood AK, Lopez-Berestein G. Nanomedicine-based approaches for the delivery of siRNA in cancer. J Intern Med 2010; 267: 44-53.
6. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine - challenge and perspectives. Angew Chem Int Ed Engl 2009; 48: 872-897
7. Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 2008; 41: 1842-1851
8. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006; 6: 688-701.
9. Vallet-Regí M. Nanostructured mesoporous silica matrices in nanomedicine. J Intern Med 2010; 267: 22-43.
10. Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 2003; 100: 6039-6044 (Pubitemid 36576927)
11. Patolsky F, Zheng G, Lieber CM. Fabrication of silicon nanowire devices for ultrasensitive, label-free, real-time detection of biological and chemical species. Nat Protoc 2006; 1: 1711-1724 (Pubitemid 46773292)
12. Freudiger CW, Min W, Saar BG et al. Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy. Science 2008; 322: 1857-1861
13. Shvedova AA, Kagan VE, Fadeel B. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Ann Rev Pharmacol Toxicol 2010; 50: 63-88.
14. Oberdörster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 2010; 267: 89-105.
15. Shvedova AA, Kagan VE. The role of nanotoxicology in realizing the 'helping without harm' paradigm of nanomedicine: lessons from studies of pulmonary effects of single-walled carbon nanotubes. J Intern Med 2010; 267: 106-118.
16. Cedervall T, Lynch I, Lindman S et al. Understanding the nanoparticle- protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007; 104: 2050-2055 (Pubitemid 46391350)
17. Jotterand F. Nanomedicine: how it could reshape clinical practice. Nanomed 2007; 2: 401-405 (Pubitemid 47365122)
18. Sanvicens N, Marco MP. Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol 2008; 26: 425-433